ArticleBMC infectious diseases2025
The relationship between admission Braden score and poor prognosis in Sepsis patients: evidence from the MIMIC-III database.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Admission Braden Scale Score Is Associated with In-Hospital Mortality in ICU Patients Admitted After a Same-Level Fall: A Retrospective Cohort Study.Diagnostics (Basel, Switzerland) · 2026Article
- Prognostic value of the Braden scale for short-term mortality in critically ill patients with traumatic brain injury.Scientific reports · 2025Article
- Braden score at ICU admission predicts 30-day mortality in acute pancreatitis.Biomolecules & biomedicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe measurement of Braden score can be used as a useful tool for clinical care. However, the relationship between the Braden score and clinical outcomes in sepsis patients remains unclear. This study aims to investigate the association between the Braden score and clinical outcomes in sepsis patients.
methodsThe Medical Information Mart for Intensive Care III (MIMIC-III) database was searched to identify patients with sepsis who had their Braden score measured. The primary outcomes were 28-day, 60-day, and 90-day mortality. Multivariate Cox regression analysis was used to clarify the relationship between Braden score and primary outcomes, and Kaplan-Meier survival analysis and stratified analysis were used to verify our findings.
resultsA total of 8,290 patients were included in our study, during the 28-day, 60-day, and 90-day follow-up periods, mortality was recorded in 1,554, 1,938, and 2,173 patients, those with lower Braden score had a 58% increased risk of 28-day mortality (hazard ratio [HR] 1.58; 95% confidence interval [CI] 1.38, 1.81), a 50% increased risk of 60-day mortality(HR 1.50; 95% CI 1.33,1.70), and a 52% increased risk of 90-day mortality(HR 1.52; 95% CI 1.35,1.70). Patients with lower Braden score received more mechanical ventilation and vasopressors, and presented with elevated WBC counts and lactate levels. In addition, lower Braden scores were also linked to increased adjusted ICU mortality and a higher incidence of AKI within the first seven days following ICU admission.
conclusionLower Braden score is an independent risk factor for mortality in critically ill patients with sepsis. Braden score can be used as a potential indicator for assessing outcomes in such patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.